These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Stimulation of cortical bone mineralization and remodeling by phosphate and 1,25-dihydroxyvitamin D in vitamin D-resistant rickets. Marie PJ; Glorieux FH Metab Bone Dis Relat Res; 1981; 3(3):159-64. PubMed ID: 6290833 [TBL] [Abstract][Full Text] [Related]
8. Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets (FHR). Glorieux FH; Bordier PJ; Marie P; Delvin EE; Travers R Adv Exp Med Biol; 1978; 103():227-32. PubMed ID: 213951 [No Abstract] [Full Text] [Related]
9. Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol. Harrell RM; Lyles KW; Harrelson JM; Friedman NE; Drezner MK J Clin Invest; 1985 Jun; 75(6):1858-68. PubMed ID: 3839245 [TBL] [Abstract][Full Text] [Related]
11. [Treatment with 1,25-dihydroxycholecalciferol in children with different types of resistant rickets]. Eggers M; Beas F Rev Chil Pediatr; 1982; 53(2):95-101. PubMed ID: 6294757 [No Abstract] [Full Text] [Related]
12. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets. Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745 [TBL] [Abstract][Full Text] [Related]
13. Early treatment of familial hypophosphataemic rickets. Roza M; Miguel MA; Galbe M; Mejido L; Mencia C Arch Dis Child; 1983 Dec; 58(12):1020-2. PubMed ID: 6689262 [TBL] [Abstract][Full Text] [Related]
14. The effect of medical therapy on dentin formation in vitamin D-resistant rickets. Seow WK Pediatr Dent; 1991; 13(2):97-102. PubMed ID: 1652747 [TBL] [Abstract][Full Text] [Related]
15. Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia. Cohanim M; DeLuca HF; Yendt ER Johns Hopkins Med J; 1972 Aug; 131(2):118-32. PubMed ID: 4340527 [No Abstract] [Full Text] [Related]
16. Linear growth in patients with hypophosphatemic vitamin D-resistant rickets: influence of treatment regimen and parental height. Balsan S; Tieder M J Pediatr; 1990 Mar; 116(3):365-71. PubMed ID: 2155316 [TBL] [Abstract][Full Text] [Related]
17. Familial hypophosphatemic rickets: bone mass measurements in children following therapy with calcitriol and supplemental phosphate. Block JE; Piel CF; Selvidge R; Genant HK Calcif Tissue Int; 1989 Feb; 44(2):86-92. PubMed ID: 2492895 [TBL] [Abstract][Full Text] [Related]
18. Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets. Rivkees SA; el-Hajj-Fuleihan G; Brown EM; Crawford JD J Clin Endocrinol Metab; 1992 Dec; 75(6):1514-8. PubMed ID: 1464657 [TBL] [Abstract][Full Text] [Related]
19. Oral manifestations of familial hypophosphatemic rickets after phosphate supplement therapy: a review of the literature and report of case. Larmas M; Hietala EL; Similä S; Pajari U ASDC J Dent Child; 1991; 58(4):328-34. PubMed ID: 1658098 [TBL] [Abstract][Full Text] [Related]
20. X-linked hypophosphatemia: effect of calcitriol on renal handling of phosphate, serum phosphate, and bone mineralization. Costa T; Marie PJ; Scriver CR; Cole DE; Reade TM; Nogrady B; Glorieux FH; Delvin EE J Clin Endocrinol Metab; 1981 Mar; 52(3):463-72. PubMed ID: 6893992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]